Aciloc 150 mg
Reduces stomach acid production to ease symptoms like heartburn, acid reflux, and internal digestive irritation.
Cadila Pharmaceuticals is one of India’s established pharmaceutical manufacturers, maintaining a large, integrated operation that serves both domestic and international markets. Their portfolio spans various therapeutic segments, focusing on affordable and accessible healthcare solutions. Four of their common generic formulations are listed here for reference, covering gastrointestinal and cardiovascular treatment.
Reduces stomach acid production to ease symptoms like heartburn, acid reflux, and internal digestive irritation.
Reduces stomach acid production to ease symptoms of acid reflux and support healing of digestive tissue.
Blocks the liver enzyme responsible for cholesterol production to lower blood lipid levels and support cardiovascular health.
Blocks an enzyme in your liver to lower blood cholesterol levels and support heart health.
Cadila Pharmaceuticals is a privately-held Indian pharmaceutical company with headquarters in Ahmedabad. Since its inception, the company has grown into a vertically integrated manufacturer, producing active pharmaceutical ingredients (APIs) and finished dosage forms. It maintains a presence in multiple segments, including cardiovascular care, gastrointestinal health, and respiratory treatments.
The company focuses on research-driven development and wide-scale manufacturing, providing products regulated for distribution across various international markets. By managing its own supply chain from raw material to finished product, the organization supports the availability of essential medications for chronic conditions.
The product catalog from this manufacturer primarily addresses chronic and acute conditions through high-volume therapeutic categories. Their focus includes gastrointestinal treatments, such as H2 receptor antagonists for acid-related disorders, and cardiovascular care, specifically the management of cholesterol levels.
Examples of these products include the Aciloc series, which is utilized for gastrointestinal acid reduction, and the Rosubest series, which consists of statin-based formulations for the management of cardiovascular health. These products reflect the company’s broader operational focus on medications meant for long-term usage by patients managing metabolic and digestive concerns.
The products listed are generic pharmaceutical formulations manufactured by Cadila Pharmaceuticals. Individual products differ in active ingredient, formulation, strength, and intended use. This page is a product catalog; it is not medical advice or an endorsement of specific products. Readers should review individual product labeling and consult a healthcare professional for guidance on which product suits their needs.